Delivery Order SPE2DB24D9144-SPE2DB25FCMWF
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $4.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $4,311.35 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on July 18, 2025, for 120 capsules of Xtandi 40 mg. The delivery order is not designated as a set-aside contract and carries an ultimate completion date of July 21, 2025. This award represents a single delivery transaction executed under DMS Pharmaceutical Group's larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $77,604.30 firm fixed-price delivery order is for the supply of 120 units of the prescription drug Xtandi 40 mg capsules, with a completion date of March 9, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The order is valued at $4,311.35 and requires the delivery of Xtandi 40 mg capsules by February 5, 2024. This delivery order is placed against DMS Pharmaceutical Group's larger indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which has a ceiling value of up to $4,999,999 and enables DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract, valued at $12,934.05, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Xtandi 40 mg capsules. DMS Pharmaceutical Group holds an Indefinite Delivery Vehicle (IDV) contract, valued up to $4,999,999, with DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a broad range of pharmaceutical...
- This federal contract award was issued by the Medical Supply Chain division of the Defense agency to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $4,311.35 firm fixed-price delivery order is for the supply of 120 capsules of the drug Xtandi 40 mg. The contract has an ultimate completion date of May 13, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 120 capsules of the drug Xtandi (40 mg) with a potential value of $25,868.10. This order is part of a larger single-award indefinite delivery vehicle (IDV) contract, worth up to $4,999,999, that DMS Pharmaceutical Group holds with DLA to provide a range of branded and generic pharmaceutical products to fulfill the recurring...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,311.35 contract is for the delivery of 120 capsules of the medication Xtandi 40 mg. The contract has an ultimate completion date of June 27, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 120 units of the drug Xtandi (40 mg capsules) with a period of performance ending on October 24, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs,...
- This is a $8,622.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the supply of 120 capsules of the prescription drug Xtandi 40 mg and has a completion date of November 7, 2024. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This federal contract award is a $4,311.35 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 120 capsules of the prescription drug Xtandi (40 mg) with a completion date of May 20, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...